Stockholders of First Horizon Pharmaceutical Corporation (NASDAQ:FHRX), voting today at the Company's 2006 Annual Meeting, approved the Company's name change to Sciele Pharma, Inc. The Company's...
First Horizon Pharmaceutical Corporation (NASDAQ:FHRX) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company's glycopyrrolate, which...
LONDON, May 22 /PRNewswire-FirstCall/ -- SkyePharma PLC (NASDAQ:SKYE) ( LSE: SKP) announces that it has entered into an agreement with First Horizon Pharmaceutical Corporation ("First Horizon...
First Horizon Pharmaceutical Corporation (NASDAQ: FHRX), a specialty pharmaceutical company, today announced that the chairman of its Board of Directors, Dr. John N. Kapoor, through an...
First Horizon Pharmaceutical Corporation (NASDAQ:FHRX) today announced that the Company has increased its adjusted diluted earnings per share (a non-GAAP measure) guidance by $0.10 to $1.27...
Exchange Offer Reduced Number of Fully Diluted Shares by Approximately 6,772,000 ? First Horizon Pharmaceutical Corporation (Nasdaq:FHRX), a specialty pharmaceutical company, today announced...
First Horizon Pharmaceutical Corporation (Nasdaq:FHRX), a specialty pharmaceutical company, today announced that Patrick Fourteau, President and Chief Executive Officer, will make a presentation...
First Horizon Pharmaceutical Corporation (NASDAQ:FHRX): ? First Quarter 2006 Results Include: ? -- Revenues increased 62% to $66.5 million compared with $41.0 million in the first quarter of...
First Horizon Pharmaceutical Corporation (Nasdaq:FHRX), a specialty pharmaceutical company, today announced that it is extending its exchange offer in which it is offering to exchange New 1.75...
First Horizon Pharmaceutical Corporation (NASDAQ:FHRX), a specialty pharmaceutical company, will release financial results for the first quarter ended March 31, 2006, after the market closes...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관